GlassScriptPhysician profile
Kimberly Ann Webb
NPI 1700490216
$1,779.86
in general payments reported to CMS, 2019-2025
22 companies · $700 in 2025
The $700 reported for 2025 was more than what 79% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $51.99 · 2022: $126 · 2023: $220 · 2024: $683 · 2025: $700.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,602.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,602.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $644.17 | 2022-2025 | Invega Sustenna, Xarelto |
| Alexion Pharmaceuticals, INC. | $250.00 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $122.86 | 2021-2025 | Xifaxan |
| Teva Pharmaceuticals USA, INC. | $120.80 | 2025 | Uzedy |
| Luye Pharma (USA) LTD. | $89.46 | 2025 | Erzofri Extended-Release |
| Axsome Therapeutics, INC. | $88.53 | 2023-2025 | Sunosi, Auvelity |
| Abbvie INC. | $85.65 | 2023-2024 | |
| Boston Scientific Corporation | $53.68 | 2022-2024 | Watchman Flx |
| Lilly USA, LLC | $48.40 | 2022-2023 | Jardiance, Emgality |
| Viatris Specialty LLC | $36.42 | 2025 | Yupelri |
| Novo Nordisk INC | $34.87 | 2024-2025 | Ozempic, Rybelsus |
| Amarin Pharma, INC. | $33.92 | 2021-2022 | |
| Amgen INC. | $27.14 | 2021-2023 | Tavneos, Enbrel |
| Pfizer INC. | $20.48 | 2025 | |
| Nestle Healthcare Nutrition INC. | $19.14 | 2023 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $17.61 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $16.97 | 2024 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $16.96 | 2022 | |
| Merck Sharp & Dohme LLC | $15.78 | 2024 | Gardasil, Capvaxive, Gardasil 9 |
| Astrazeneca Pharmaceuticals LP | $13.60 | 2024 | Seroquel |
| Eisai INC. | $12.09 | 2022 | |
| Glaxosmithkline, LLC. | $11.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.